Psychedelic Industry News

Michigan Rep. Jack Bergman Says Psychedelic Treatment Research Has Reached a New Moment

Rep. Jack Bergman, a Michigan Republican and one of Congress’s leading voices on psychedelics, says the window for action has opened wider.

Psychedelic Drug Market Could Reach $14.9 Billion by 2035, Report Says

The forecast reflects a shift in mental health, where ketamine, psilocybin, MDMA, and other compounds are moving from fringe to mainstream.

Lawmakers Push FDA to Speed Up Psychedelic Therapy Reviews

They asked the agency to advance evaluations of rapid acting therapeutics for PTSD, traumatic brain injury and related conditions.

How Media Outlets Are Reacting to Trump’s Psychedelics Executive Order

Trump’s executive order on psychedelics pushed a once fringe issue into the center of health policy. The coverage shows a clear pattern.

FDA Grants Priority Vouchers to Three Psychedelic Drug Programs

The FDA's decision could deliver the first psychedelic medicine approved by the FDA as soon as this summer.

Why the Trump Psychedelics Executive Order Makes This the Most Important Moment to Join the Healing Health Alliance

Something happened in Washington last week that changes the economics of running a ketamine or psychedelic-adjacent clinic in America. President Trump’s April 18, 2026 executive order — Accelerating Medical Treatments for Serious Mental Illness — formally directed the FDA to expedite review of psychedelic therapies, instructed the DEA to remove administrative barriers to research and […]

Trump Signs Executive Order to Accelerate FDA Review of Psychedelic Therapies

Trump framed the order as a response to the mental health crisis facing American veterans. Psychedelic therapy advocates are watching the move closely.

Magic Mushrooms Move Mainstream as Science and Policy Lag Behind

Psilocybin is moving into the mainstream faster than science and policy can keep up. Will this interest in move the regulatory needle?

Congress Moves to Open the Door to Psychedelic Therapy for Veterans

A bipartisan group of military veterans serving in the U.S. Senate introduced legislation that could fundamentally change how the VA treats mental health. Senate Bill 4220, the Veterans Health Administration Novel Therapeutics Preparedness Act, would build the internal infrastructure the VA needs to deploy psychedelic therapies once the FDA approves them. Advocates call it the […]

Scientists Just Engineered a Plant That Produces Five Psychedelics at Once

The compounds include psilocin and psilocybin from magic mushrooms, DMT from the ayahuasca plant, and bufotenin and 5-methoxy-DMT secreted by the Sonoran Desert toad.